Faculty Member – Brad Martin

Bradley C. Martin, PharmD, PhDPicture of Bradley Martin

Professor, Division Head of Pharmaceutical Evaluation and Policy

Department of Pharmacy Practice
Phone: (501) 603-1992
Fax: (501) 686-5156
Office: RAHN 6251
Email: bmartin@uams.edu

Education & Training

1989 Pharm.D. University of Illinois Chicago
1993 Ph.D. University of Georgia

Teaching Responsibilities

PHPR 5642 Evidence-based Medicine and Pharmacoeconomics: Meta-analysis, Overview of Pharmacoeconomic Designs, Interpreting Cost Studies, Interpreting Cost-effectiveness modeling studies, Using evidence to influence formulary decisions

PHSC 5353 Pharmacoeconomics and Health Care Technology Assessment: History of economic evaluations, Gov. projects, Theoretical basis of pharmacoeconomics, Welfare Economics, Review of basic finance & accounting, Time value of money & Discounting, Types of economic costs, Identifying costs, Measuring cost, Valuing cost, Macro-costing, Micro-costing, Introduction to Pharmacoeconomic Designs, Cost of Illness studies, Cost Minimization analyses, Cost Identification studies, Cost Effectiveness Analysis, Cost Utility Analysis, Interpreting Marginal Cost Effectiveness Ratios, Strong and Weak Dominance, The “Reference Case” Analysis, Introduction to Decision Analysis, Modeling a Clinical Decision, Becoming familiar with TreeAge Pro, Building Deterministic Decision Trees, Decision Tree Nodes, Branches, and Payoffs, Using Variables in TreeAge, Using Formulas in TreeAge, Sensitivity Analyses and Thresholds, Distributions in TreeAge, Monte Carlo Simulations, Tracker Variables, Markov Modeling, Data Sources for Decision Modeling, Cost Benefit Analysis, Willingness to Pay Methods, Deriving Utility weights for Cost Effectiveness Analysis, Rating Scale, Time Trade-Off, Standard Gamble

PHSC5333 Applied Research Methods using Retrospective Data Sources: Types and Sources of Health Care Data, The basic structure and organization of health care claims data, Inputting Data into SAS, Managing SAS Libraries to store data, SAS data step, Prescription Claims Information and Sources, Prescription Codes and National Council for Prescription Drug Programs (NCPDP), Overview of PBMs, SAS functions, IF-THEN statements, Health Care Codes, ICD-9-CM and ICD-10 codes, DRGs, UB-92 Forms, SAS dates and organizing ‘time’ in your programs, SAS Informats and Formats, CPT-4 and HCPCS codes, Validating Data, Proc Contents, Proc Print, Proc Means, Proc Freq, Medicaid Eligibility and Eligibility Types, Proc Sort, Proc Tabulate, Long Term Care, Modifying and Combining Data in SAS, Merging Data, HIPAA and IRB and Administrative Claims Data, SAS Arrays, SAS Lag and Retain commands, Observational Study Designs, Threats to Internal Validity, Causal Associations, SAS Macros, Basic Statistical Reporting, Good Research Practices with Observational data, Cohort Studies, Case Control Studies, Basic OLS Regression and Selection Bias, Proc REG, Proc GLM, Regression Diagnostics in SAS, Overview of Non-Medicaid Administrative Claims Data, Time Series Designs, Proc AUTOREG, Introduction to ARIMA.modeling, Risk Adjustment and Predictive Modeling, Transferring and Exporting SAS files, Propensity Scores, Proc Logisitic and Propensity Scoring in SAS

PHSC 5323 Foundations of Pharmaceutical Evaluation and Policy Research Methods: Funding Sources for PEP Research and Developing a Budget, Pharmaceutical Research Contracts and Grant programs, Government and Organizational sources for funding, Dissertation grant programs, Graduate Fellowships, Developing a budget for retrospective observational studies, Proposal review process/authorship, Presentation/Publication of research, Data Sources, Administrative data bases, Defining different levels of measurement, Evaluating and conducting Reliability assessment studies, Content, Construct, and Criterion validity assessment of scales, Evaluating and conducting validity assessment studies, Experimental designs, Sources of invalidity, Hierarchy of Designs
Pre-experimental, quasi experimental, and truly experimental designs, Standard sources of invalidity to consider when evaluating a study designs, Quasi Experimental Designs, Validity considerations of observational studies with non-equivalent control groups,Non Experimental Designs, Case Reports.

PHPR 5734 Pharmacy Management: Financial Statements (P&L Statement, Balance Sheet), Financial Performance Measures.

Research & Scholarly Interests

Pharmaceutical Policy Analyses
Burden of Illness Studies
Pharmacoepidemiologic and Pharmacoeconomic Research using Large Administrative Databases
Risk Assessment and Risk Adjustment
Cost Effectiveness Modeling

Honors & Awards

  • ISPOR Distinguished Service Award: Task Force Chair Assessing Retrospective Studies for Health Care Decision Makers 2014
  • ISPOR Distinguished Service Award: Short Course Development and Quality Assurance Committee Chair (2012-2014)
  • Exceptional Reviewer: JMCP – 2013
  • Exceptional Reviewer: J Pharmacoepi and Drug Safety – 2012
  • Editorial Board Member: Current Research and Medical Opinion, Journal of Managed Care Pharmacy
  • Journal Referee: JAMA, Medical Care, Value in Health, Journal of Managed Care Pharmacy (Selected as Gold Review Panel 2002-03), Annals of Pharmacotherapy
  • Best Student Poster Award: International Society for Pharmacoeconomics and Outcomes Research European Conference, Athens, Greece, 2008.
  • Pharmacy Faculty New Investigator: AACP 1996; AACP-AFPE, 2004
  • Pharmacy Practice Research Award: American Society of Health System Pharmacy Foundation 2003
  • Fellow: American Foundation for Pharmaceutical Education, 2004.
  • Faculty Advisor: UGA AMCP First place student chapter National AMCP P&T Competition, 2003.
  • Best Poster Presentation Nominee: International Society for Pharmacoeconomics and Outcomes Research Conference, Washington DC, 2003
  • Best Poster Nominee: International Society for Pharmacoeconomics and Outcomes Research Fifth Annual European Congress, Rotterdam, Netherlands, 2002
  • UGA Career Development Certificate of Recognition: For contributiions to the career development of UGA students, (2002, 2003).
  • International Society for Pharmacoeconomics and Outcomes Research: Chair of the Task Force on Retrospective Data Base Studies. 2002
  • Who’s Who in Medicine and Healthcare, 4th Edition; Executive and Professional Registry, 2003
  • Third Annual National Institutes for Health Care Management Research Award: Finalist, 1996
  • Rho Chi Honor Society: member


  • International Society for Pharmacoeconomics and Outcomes Research
  • Academy of Managed Care Pharmacy
  • American Association of Colleges of Pharmacy


Curriculum Vitae